3 The Availability of Molecular Profiling Results at New Patient Review in NSCLC and the Impact on Patient Care

Optimal systemic anti-cancer therapy (SACT) for non-small cell lung cancer (NSCLC) is dependent on the results of molecular profiling to direct precision medicine. Delays in the availability of results in the clinic can delay care.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Matt Church, Mathew Carter, Yvonne Summers, Fabio Gomes, Paul Taylor, Sarah Hughes, Raffaele Califano, Fiona Blackhall, Colin Lindsay, Laura Cove-Smith Tags: Basic Science Source Type: research